The primary end point was objective response rate (RR) in the first 100 assessable patients.
主要实验终止点是前面100位可评估患者的客观反应率。
The response rate (RR), the clinical benefit rate (CBR), time of tumor progression (TTP) and the quality of life (QOL) were observed.
观察有效率(RR)、临床受益率(CBR)、肿瘤进展时间(TTP)、生活质量(QOL)及不良反应。
The response rate (RR), the clinical benefit rate (CBR), time of tumor progression (TTP) and the quality of life (QOL) were observed.
观察有效率(RR)、临床受益率(CBR)、肿瘤进展时间(TTP)、生活质量(QOL)及不良反应。
应用推荐